Lifeboat Foundation

Elon Musk has revealed the official launch date for Tesla’s “Cyberpunk” Pickup Truck. According to the CEO, the upcoming vehicle would be released on November 21, 2019 at the SpaceX rocket factory in Hawthorne, CA.

Musk’s update formally ends a period of speculations that have long swept the electric car community with regards to the unveiling of the Tesla Pickup Truck. The CEO, after all, has praised the vehicle as one of his personal favorites. Yet, despite this, Tesla has been able to keep details of the Cybertruck secret, with zero sightings or spy shots of the vehicle to date.

ROCHESTER, Minn. — A Mayo Clinic study finds that applying artificial intelligence (AI) to a widely available, inexpensive test – the electrocardiogram (EKG) – results in a simple, affordable early indicator of asymptomatic left ventricular dysfunction, which is a precursor to heart failure. The research team found that the AI/EKG test accuracy compares favorably with other common screening tests, such as mammography for breast cancer. The findings were published in Nature Medicine.

Asymptomatic left ventricular dysfunction is characterized by the presence of a weak heart pump with a risk of overt heart failure. It affects 7 million Americans, and is associated with reduced quality of life and longevity. But asymptomatic left ventricular dysfunction is treatable when identified.

UPS Flight Forward recently was awarded their Part 135 certification from the Federal Aviation Administration, which allows them to make deliveries by drone throughout the U.S. This week, UPS in partnership with CVS made their first residential delivery by drone by dropping off prescription drugs from a CVS pharmacy directly to a consumer’s home.

A group of scientists led by Artem Oganov of Skoltech and the Moscow Institute of Physics and Technology, and Ivan Troyan of the Institute of Crystallography of RAS has succeeded in synthesizing thorium decahydride (ThH10), a new superconducting material with the very high critical temperature of 161 kelvins. The results of their study, supported by a Russian Science Foundation grant, were published in the journal Materials Today on November 6, 2019.

A truly remarkable property of quantum materials, superconductivity is the complete loss of electrical resistance under quite specific, and sometimes very harsh, conditions. Despite the tremendous potential for quantum computers and high-sensitivity detectors, the application of superconductors is hindered by the fact that their valuable properties typically manifest themselves at very low temperatures or extremely high pressures.

Until recently, the list of superconductors was topped by a mercury-containing cuprate, which becomes superconducting at 135 kelvins, or −138 degrees Celsius. This year, lanthanum decahydride, LaH10, set a new record of −13 C, which is very close to room temperature. Unfortunately, that superconductor requires pressures approaching 2 million atmospheres, which can hardly be maintained in real-life applications. Scientists, therefore, continue their quest for a superconductor that retains its properties at standard conditions.

In a future where regeneration technology lets humans live indefinitely, a cop and a troubled young woman investigate a strange wave of youth suicides.

The Kidney Project, a national effort to develop an implantable bio-artificial kidney that could eliminate the need for dialysis, will announce a key milestone in a November 7, 2019 presentation at the American Society of Nephrology Kidney Week 2019 conference in Washington, DC.

The team will report that UC San Francisco scientists have successfully implanted a prototype kidney bioreactor containing functional human kidney cells into pigs without significant safety concerns. The device, which is about the size of a deck of cards, did not trigger an immune reaction or cause blood clots in the animals, an important milestone on the road to future human trials.

“This is the first demonstration that kidney cells can be implanted successfully in a large animal without immunosuppression and remain healthy enough to perform their function. This is a key milestone for us,” said Kidney Project co-lead Shuvo Roy, Ph.D., a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine. “Based on these results, we can now focus on scaling up the bioreactor and combining it with the blood filtration component of the artificial kidney.”

While many high-school sophomores are busy partying and socializing, Jack Andraka developed a test for pancreatic cancer that is the first test that detects the disease and tumors before they get out of hand.

And with pancreatic cancer having the lowest survival rate of any cancer, he truly accomplished something amazing with his work.

Continue reading “15-Year-Old Creates Cancer Test That Is 26,000 Times Less Expensive With 100% Accuracy” »

A company claims to make the world’s first humanoid android and offers ‘digital immortality.

Read more